Reference health
Sex and Gender Disparities in Melanoma
2 of 200 checkable references need attention · checked 2026-07-22
At the dated check, the references listed below either did not resolve in Crossref or DataCite, or carried a retraction notice. Each one is shown with the registry record that put it there.
16 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
References needing attention
marked retracted — notice via Crossref, record curated by Retraction Watch10.1074/jbc.M806041200
MicroRNA-221/222 Negatively Regulates Estrogen Receptorα and Is Associated with Tamoxifen Resistance in Breast Cancer
marked retracted — notice via Crossref, record curated by Retraction Watch10.1111/jcmm.14348
<i>Retracted:</i>
microRNA‐374 inhibits proliferation and promotes apoptosis of mouse melanoma cells by inactivating the Wnt signalling pathway through its effect on tyrosinase
The 198 checked references that resolve
resolves10.1002/ijc.31937
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
resolves10.1001/jamadermatol.2018.0028
Prevalence of Sun Protection Use and Sunburn and Association of Demographic and Behaviorial Characteristics With Sunburn Among US Adults
resolves10.3149/jms.0901.81
Behavioral Factors Associated with Disease, Injury, and Death among Men: Evidence and Implications for Prevention
resolves10.1200/JCO.2011.38.0584
Superior Outcome of Women With Stage I/II Cutaneous Melanoma: Pooled Analysis of Four European Organisation for Research and Treatment of Cancer Phase III Trials
resolves10.1038/jid.2010.354
Gender Differences in Melanoma Survival: Female Patients Have a Decreased Risk of Metastasis
resolves10.1200/JCO.2012.44.5031
Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
resolves10.1186/s13293-016-0070-1
Sex-specific genetic effects associated with pigmentation, sensitivity to sunlight, and melanoma in a population of Spanish origin
resolves10.1016/j.jsbmb.2013.02.006
Steroidogenesis in the skin: Implications for local immune functions
resolves10.1097/DAD.0b013e3182914c64
Immunohistochemical Expression of Hormone Receptors in Melanoma of Pregnant Women, Nonpregnant Women, and Men
resolves10.1111/j.1346-8138.2008.00447.x
Expression of estrogen receptor β in normal skin, melanocytic nevi and malignant melanomas
resolves10.3390/ijms21051776
A Possible Link of Genetic Variations in ER/IGF1R Pathway and Risk of Melanoma
resolves10.3389/fonc.2019.01110
Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice
resolves10.1371/journal.pone.0134396
Estrogen Receptor β Agonists Differentially Affect the Growth of Human Melanoma Cell Lines
resolves10.1016/j.cbi.2017.09.017
The activation of the G protein-coupled estrogen receptor (GPER) inhibits the proliferation of mouse melanoma K1735-M2 cells
resolves10.1111/jdv.14304
Expression of G protein‐coupled oestrogen receptor in melanoma and in pregnancy‐associated melanoma
resolves10.3934/molsci.2015.3.294
Sex steroid hormone receptors, their ligands, and nuclear and non-nuclear pathways
resolves10.1097/00008390-200212000-00002
Androgen receptors in human melanoma cell lines IIB-MEL-LES and IIB-MEL-IAN and in human melanoma metastases
resolves10.1038/s41416-019-0411-z
Reproductive factors, exogenous hormone use and incidence of melanoma among women in the United States
resolves10.1002/cncr.23359
Age and gender are significant independent predictors of survival in primary cutaneous melanoma
resolves10.1097/CMR.0b013e32834577c8
Sex differences in survival of cutaneous melanoma are age dependent
resolves10.1002/ijc.31644
Oral contraceptive use and cutaneous melanoma risk: a French prospective cohort study
resolves10.1002/ijc.30878
Menopausal hormone therapy and risk of melanoma: Do estrogens and progestins have a different role?
resolves10.1016/j.ejca.2017.07.012
Menopausal hormone therapy and cancer risk: An overestimated risk?
resolves10.1093/humrep/dez222
Hormone replacement therapy and the risk of melanoma in post-menopausal women
resolves10.1158/1055-9965.EPI-19-0554
Menopausal Hormone Therapy and Risk of Melanoma: A Nationwide Register-Based Study in Finland
resolves10.1016/j.respe.2018.05.153
Oral contraceptive use and cutaneous melanoma risk: A French prospective cohort study
resolves10.1097/DSS.0000000000000406
Does Pregnancy After a Diagnosis of Melanoma Affect Prognosis? Systematic Review and Meta-analysis
resolves10.1046/j.1523-1747.2001.01422.x
17β-estradiol, Progesterone, and Dihydrotestosterone Suppress the Growth of Human Melanoma by Inhibiting Interleukin-8 Production
resolves10.1590/S0100-879X2004000600016
Biological activity and binding of estradiol to SK-Mel 23 human melanoma cells
resolves10.1097/00008390-200304000-00003
Cell cycle block and apoptosis induction in a human melanoma cell line following treatment with 2-methoxyoestradiol
resolves10.1002/ijc.20473
<i>In vitro</i> and <i>in vivo</i> antitumor effect of 2‐methoxyestradiol on human melanoma
resolves10.1097/00008390-199504000-00002
Sex-dependent liver metastasis of human melanoma lines in SCID mice
resolves10.1016/j.phrs.2017.02.013
Inhibition of proliferation and invasion in 2D and 3D models by 2-methoxyestradiol in human melanoma cells
resolves10.7554/eLife.31770
Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade
resolves10.1073/pnas.1803291115
Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis
resolves10.1016/j.yexcr.2009.04.009
Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways
resolves10.1186/s11658-017-0068-7
Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice
resolves10.1038/onc.2016.330
Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals
resolves10.1016/S0022-4804(03)00005-2
Androgen blockade enhances response to melanoma vaccine 1 1This work was supported in part by a Young Investigator Award from the American Society of Clinical Oncology (to Dr. Hsueh). Presented at the annual meeting of the American Society of Clinical Oncology, San Francisco, May 12–15, 2001.
resolves10.3389/fendo.2016.00140
Estrogen Receptor β in Melanoma: From Molecular Insights to Potential Clinical Utility
resolves10.1016/j.ejmech.2017.11.056
Tamoxifen a pioneering drug: An update on the therapeutic potential of tamoxifen derivatives
resolves10.1016/S0303-7207(00)00253-7
Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway
resolves10.1111/j.1365-4632.2010.04529.x
Tamoxifen vs. non‐tamoxifen treatment for advanced melanoma: a meta‐analysis
resolves10.1016/j.ejphar.2015.07.023
Rethinking tamoxifen in the management of melanoma: New answers for an old question
resolves10.1186/1471-2407-13-425
Estrogen receptor alpha/beta ratio and estrogen receptor beta as predictors of endocrine therapy responsiveness–a randomized neoadjuvant trial comparison between anastrozole and tamoxifen for the treatment of postmenopausal breast cancer
resolves10.1677/jme.1.01784
Influence of oestradiol and tamoxifen on oestrogen receptors-α and -β protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells
resolves10.1016/j.jsbmb.2016.06.012
G protein-coupled estrogen receptor enhances melanogenesis via cAMP-protein kinase (PKA) by upregulating microphthalmia-related transcription factor-tyrosinase in melanoma
resolves10.7554/eLife.15104
Sex steroids regulate skin pigmentation through nonclassical membrane-bound receptors
resolves10.1007/s11596-010-0220-3
Effects of progesterone on the growth regulation in classical progesterone receptor-negative malignant melanoma cells
resolves10.4236/cellbio.2014.32007
&lt;i&gt;In-Vitro&lt;/i&gt; Effect of Sex Steroids on Mouse Melanoma (B16F10) Cell Growth
resolves10.1111/j.1600-0749.1995.tb00654.x
Atypical Androgen Receptor in the Human Melanoma Cell Line IIB‐MEL‐J
resolves10.1016/j.celrep.2019.04.101
The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21
resolves10.1016/j.ygeno.2019.11.005
The androgen receptor expression and association with patient's survival in different cancers
resolves10.1016/S1470-2045(18)30261-4
Cancer immunotherapy efficacy and patients' sex: a systematic review and meta-analysis
resolves10.1001/jamaoncol.2018.5904
Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers
resolves10.3389/fimmu.2015.00635
The Immune System Is a Natural Target for Estrogen Action: Opposing Effects of Estrogen in Two Prototypical Autoimmune Diseases
resolves10.1016/j.cellimm.2015.01.018
Estrogen receptors regulate innate immune cells and signaling pathways
resolves10.1016/j.jaut.2009.12.007
Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice
resolves10.1016/j.cellimm.2007.10.008
Regulation of dendritic cell differentiation and function by estrogen receptor ligands
resolves10.3389/fimmu.2018.00552
Sexual Dimorphism of Immune Responses: A New Perspective in Cancer Immunotherapy
resolves10.1038/s41591-018-0085-8
A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
resolves10.1182/blood-2011-08-371831
The TLR-mediated response of plasmacytoid dendritic cells is positively regulated by estradiol in vivo through cell-intrinsic estrogen receptor α signaling
resolves10.4049/jimmunol.1303400
X-Chromosome Complement and Estrogen Receptor Signaling Independently Contribute to the Enhanced TLR7-Mediated IFN-α Production of Plasmacytoid Dendritic Cells from Women
resolves10.1046/j.1523-1747.2002.01847.x
Human Keratinocytes Express Functional CD14 and Toll-Like Receptor 4
resolves10.5021/ad.2010.22.4.486
Activation of Toll-like Receptors 1, 2, 4, 5, and 7 on Human Melanocytes Modulate Pigmentation
resolves10.1158/1535-7163.MCT-08-0582
Activation of toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors
resolves10.1038/emboj.2010.94
TLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cells
resolves10.1038/ni758
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
resolves10.1046/j.0366-077X.2003.05626.x
The use of Toll-like receptor-7 agonist in the treatment of basal cell carcinoma: an overview
resolves10.1023/B:APPT.0000025805.55340.c3
Immune modulation and apoptosis induction: Two sides of the antitumoral activity of imiquimod
resolves10.1158/0008-5472.CAN-15-1490
Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment
resolves10.1158/0008-5472.CAN-12-0337
Augmentation of Therapeutic Responses in Melanoma by Inhibition of IRAK-1,-4
resolves10.1093/nar/gkv615
FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma
resolves10.1038/srep30405
Melanoma dormancy in a mouse model is linked to GILZ/FOXO3A-dependent quiescence of disseminated stem-like cells
resolves10.1158/2326-6066.CIR-16-0382
Role of NOX2-Derived Reactive Oxygen Species in NK Cell–Mediated Control of Murine Melanoma Metastasis
resolves10.1046/j.1365-2133.2003.05303.x
Oxidative stress in malignant melanoma and non-melanoma skin cancer
resolves10.1111/j.1755-148X.2010.00694.x
Reactive oxygen species and melanoma: an explanation for gender differences in survival?
resolves10.1515/hsz-2018-0327
Oxidative stress and antioxidants in the pathophysiology of malignant melanoma
resolves10.1016/j.febslet.2008.01.034
Redox state and gender differences in vascular smooth muscle cells
resolves10.1111/j.1440-1681.2007.04732.x
EFFECT OF GENDER AND SEX HORMONES ON VASCULAR OXIDATIVE STRESS
resolves10.1016/j.yexcr.2004.07.014
Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells
resolves10.1007/s00262-009-0701-z
HLA and melanoma: multiple alterations in HLA class I and II expression in human melanoma cell lines from ESTDAB cell bank
resolves10.1007/s00262-010-0893-2
The escape of cancer from T lymphocytes: immunoselection of MHC class I loss variants harboring structural-irreversible “hard” lesions
resolves10.1002/(SICI)1097-4652(200003)182:3<323::AID-JCP2>3.0.CO;2-#
T‐cell recognition of melanoma‐associated antigens
resolves10.1158/0008-5472.CAN-06-2522
A Causal Role for the Human Tumor Antigen Preferentially Expressed Antigen of Melanoma in Cancer
resolves10.1084/jem.188.6.1005
Translation of a Retained Intron in Tyrosinase-related Protein (TRP) 2 mRNA Generates a New Cytotoxic T Lymphocyte (CTL)-defined and Shared Human Melanoma Antigen Not Expressed in Normal Cells of the Melanocytic Lineage
resolves10.1034/j.1600-065X.2002.18803.x
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
resolves10.18632/oncotarget.22190
Immune system and melanoma biology: a balance between immunosurveillance and immune escape
resolves10.4049/jimmunol.132.2.656
Sex-associated differences in the regulation of immune responses controlled by the MHC of the mouse.
resolves10.1001/jama.295.12.1428
The Role of X Inactivation and Cellular Mosaicism in Women's Health and Sex-Specific Diseases
resolves10.1016/j.cellimm.2011.10.009
Gender effect on in vitro lymphocyte subset levels of healthy individuals
resolves10.1002/cyto.b.10011
Normal values of CD4 and CD8 lymphocyte subsets in healthy indian adults and the effects of sex, age, ethnicity, and smoking
resolves10.3389/fonc.2014.00266
Circulating Type-1 Anti-Tumor CD4<sup>+</sup>T Cells are Preferentially Pro-Apoptotic in Cancer Patients
resolves10.1007/s00262-004-0653-2
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
resolves10.1038/nm730
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
resolves10.1111/j.1365-2567.2008.03051.x
Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin‐17 production via programmed death 1
resolves10.1007/s11596-009-0116-2
Costimulatory molecule B7-H1 on the immune escape of bladder cancer and its clinical significance
resolves10.4049/jimmunol.1000496
B7-H1–Dependent Sex-Related Differences in Tumor Immunity and Immunotherapy Responses
resolves10.1073/pnas.0307323101
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers
resolves10.1007/s10549-011-1872-9
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
resolves10.1158/0008-5472.CAN-09-2206
Widespread Estrogen-Dependent Repression of microRNAs Involved in Breast Tumor Cell Growth
resolves10.1016/j.jsbmb.2013.03.003
Estrogen receptor beta: Tissue distribution and the still largely enigmatic physiological function
resolves10.1093/jnci/djq102
MicroRNA Cluster 221-222 and Estrogen Receptor α Interactions in Breast Cancer
resolves10.1371/journal.pone.0087563
Elevated MiR-222-3p Promotes Proliferation and Invasion of Endometrial Carcinoma via Targeting ERα
resolves10.1586/17446651.2015.1099430
miRNA clusters as therapeutic targets for hormone-resistant breast cancer
resolves10.1158/0008-5472.CAN-07-2538
The Promyelocytic Leukemia Zinc Finger–MicroRNA-221/-222 Pathway Controls Melanoma Progression through Multiple Oncogenic Mechanisms
resolves10.1111/j.1755-148X.2011.00881.x
Constitutive activation of the ETS‐1‐miR‐222 circuitry in metastatic melanoma
resolves10.1002/ijc.28097
The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR‐221&222‐c‐FOS pathway
resolves10.18632/oncotarget.24085
SCD5 restored expression favors differentiation and epithelial-mesenchymal reversion in advanced melanoma
resolves10.1038/onc.2015.357
AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression
resolves10.1038/s41419-019-1888-3
X-chromosome-linked miR548am-5p is a key regulator of sex disparity in the susceptibility to mitochondria-mediated apoptosis
resolves10.1002/1097-0215(200002)9999:9999<::AID-IJC1048>3.0.CO;2-F
Childhood cancer registrations in the developing world: Still more boys than girls
resolves10.1073/pnas.1105398108
NF-κB dysregulation in microRNA-146a–deficient mice drives the development of myeloid malignancies
resolves10.1016/j.cytogfr.2019.12.010
Tumor-derived extracellular vesicles and microRNAs: Functional roles, diagnostic, prognostic and therapeutic options
resolves10.1186/s12967-016-0811-2
Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma
resolves10.4149/neo_2017_311
The potential roles of vesicle-enclosed miRNAs in communication between macrophages and cancer cells in tumor microenvironment
resolves10.3390/ijms19030879
The Oncogenic Relevance of miR-17-92 Cluster and Its Paralogous miR-106b-25 and miR-106a-363 Clusters in Brain Tumors
resolves10.18632/oncotarget.15213
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
resolves10.1158/0008-5472.CAN-06-4478
Oncogenic Potential of the <i>miR-106-363</i> Cluster and Its Implication in Human T-Cell Leukemia
resolves10.1038/nature06607
Regulation of progenitor cell proliferation and granulocyte function by microRNA-223
resolves10.1186/1471-2164-8-240
Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids
resolves10.1038/onc.2014.294
CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth
resolves10.1158/1078-0432.CCR-08-3172
Regulation of <i>RUNX3</i> Tumor Suppressor Gene Expression in Cutaneous Melanoma
resolves10.1084/jem.20191388
Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes
resolves10.1158/1078-0432.CCR-14-2947
MicroRNA-374b Suppresses Proliferation and Promotes Apoptosis in T-cell Lymphoblastic Lymphoma by Repressing AKT1 and Wnt-16
resolves10.1016/j.imlet.2020.04.002
Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy
resolves10.1038/emm.2014.63
miR-98 suppresses melanoma metastasis through a negative feedback loop with its target gene IL-6
resolves10.1016/j.biochi.2018.04.016
MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10
resolves10.1038/s41586-018-0253-5
Induction of innate immune memory via microRNA targeting of chromatin remodelling factors
resolves10.1089/jwh.2019.7851
Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort
resolves10.1186/s12939-019-0954-x
Women in clinical trials: a review of policy development and health equity in the Canadian context
resolves10.1093/jnci/djy023
Risk Stratification for Melanoma: Models Derived and Validated in a Purpose-Designed Prospective Cohort
resolves10.1016/S0140-6736(16)32393-5
Sex-related reporting in randomised controlled trials in medical journals
resolves10.1186/s41073-016-0007-6
Sex and Gender Equity in Research: rationale for the SAGER guidelines and recommended use
resolves10.1200/JCO.2019.37.15_suppl.11588
Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials.
resolves10.1016/j.jaad.2015.02.1113
Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma
resolves10.1038/s41591-019-0448-9
Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma
resolves10.1080/14740338.2019.1607289
Update on BRAF and MEK inhibition for treatment of melanoma in metastatic, unresectable, and adjuvant settings
resolves10.1038/nrclinonc.2016.25
The future of cancer treatment: immunomodulation, CARs and combination immunotherapy
resolves10.1056/NEJMoa1904059
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
resolves10.18632/oncotarget.22242
The sexist behaviour of immune checkpoint inhibitors in cancer therapy?
resolves10.1002/ijc.31301
Correlation between sex and efficacy of immune checkpoint inhibitors (<scp>PD</scp>‐1 and <scp>CTLA</scp>‐4 inhibitors)
resolves10.20944/preprints201808.0307.v1
Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials
resolves10.1016/S1470-2045(18)30078-0
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
resolves10.1530/EJE-16-0834
Modulation of SHBG binding to testosterone and estradiol by sex and morbid obesity
resolves10.1093/annonc/mdx818
Immune-related adverse events of immune checkpoint inhibitors and the impact of sex—what we know and what we need to learn
resolves10.3390/molecules24183214
Sex Differences in Cancer Immunotherapy Efficacy, Biomarkers, and Therapeutic Strategy
The 16 references without a DOI — listed, not checked
no DOI — not checkedItalian Association of Medical Oncology (AIOM), and Italian Association of Tumor Registries (Airtum) (2020, July 04). The Numbers of Cancer in Italy 2019, Available online: http://www.salute.gov.it/portale/news/p3_2_1_1_1.jsp?lingua=italiano&menu=notizie&p=dalministero&id=3897.
no DOI — not checkedEstrogen receptor expression in cutaneous melanoma: A real-time reverse transcriptase-polymerase chain reaction and immunohistochemical study
no DOI — not checkedEffect of 17 beta-estradiol on the growth of estrogen receptor positive human melanoma in vitro and in athymic mice
no DOI — not checkedEndocrine factors influencing melanoma progression
no DOI — not checkedEstrous cycle influences organ-specific metastasis of B16F10 melanoma cells
no DOI — not checkedIn vitro effect of progesterone on human melanoma (BLM) cell growth
no DOI — not checkedIn-vitro rescue and recovery studies of human melanoma (BLM) cell growth, adhesion and migration functions after treatment with progesterone
no DOI — not checkedProgesterone and Melanoma Cells: An Old Story Suspended between Life and Death
no DOI — not checkedExpression of estrogen-related receptor beta (ERRβ) in human skin
no DOI — not checkedInteraction of Human Malignant Melanoma (ST-ML-12) Tumor Spheroids with Endothelial Cell Monolayers. Damage to Endothelium by Oxygen-Derived Free Radicals
no DOI — not checkedSex-based differences in autoimmune diseases
no DOI — not checkedCD4+CD25(hi) Regulatory T Cells in Healthy Males and Females Mediate Gender Difference in the Prevalence of Autoimmune Diseases
no DOI — not checkedInhibition of MicroRNA-221 and 222 Enhances Hematopoietic Differentiation from Human Pluripotent Stem Cells via c-KIT Upregulation
no DOI — not checkedMicroRNA-363-3p/p21 (Cip1/Waf1) Axis Is Regulated by HIF-2α in Mediating Stemness of Melanoma Cells
no DOI — not checkedThe histogenesis and biological behavior of primary human malignant melanomas of the skin
no DOI — not checkedItalian Official Gazette GU Series General n.25 (2020, July 04). Delegation to the Government Concerning Clinical Trials of Medicinal Products and Provisions for the Reorganization of the Health Professions and for the Healthcare Officials of the Ministry of Health. Available online: https://www.gazzettaufficiale.it/eli/gu/2018/01/31/25/sg/pdf.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.3390/cancers12071819"><img src="https://citestamp.com/citestamped/10.3390/cancers12071819/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.3390/cancers12071819)